---
title: "Abiraterone Acetate - Malignant Tumor Of Prostate - 3"
sidebar: mydoc_sidebar
permalink: db05812-mesh-d011471-3.html
toc: false 
---


Path ID: `DB05812_MESH_D011471_3`
{% include image.html url="images/db05812-mesh-d011471-3.png" file="db05812-mesh-d011471-3.png" alt="db05812-mesh-d011471-3" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000069501">MESH:D000069501 </a> | abiraterone acetate | Drug |
| <a href="https://identifiers.org/UniProt:P15538">UniProt:P15538 </a> | Cytochrome P450 11B1, mitochondrial | Protein |
| <a href="https://identifiers.org/UniProt:P08686">UniProt:P08686 </a> | Steroid 21-hydroxylase | Protein |
| <a href="https://identifiers.org/UniProt:P05177">UniProt:P05177 </a> | Cytochrome P450 1A2 | Protein |
| <a href="https://identifiers.org/UniProt:P11712">UniProt:P11712 </a> | Cytochrome P450 2C9 | Protein |
| <a href="https://identifiers.org/UniProt:P08684">UniProt:P08684 </a> | Cytochrome P450 3A4 | Protein |
| <a href="https://identifiers.org/GO:0006704">GO:0006704 </a> | glucocorticoid biosynthetic process | BiologicalProcess |
| <a href="https://identifiers.org/GO:0061370">GO:0061370 </a> | testosterone biosynthetic process | BiologicalProcess |
| <a href="https://identifiers.org/HP:0030088">HP:0030088 </a> | Increased serum testosterone level | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D011471">MESH:D011471 </a> | Malignant tumor of prostate | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Abiraterone Acetate | DECREASES ACTIVITY OF | Cytochrome P450 11B1, Mitochondrial |
| Abiraterone Acetate | DECREASES ACTIVITY OF | Steroid 21-Hydroxylase |
| Abiraterone Acetate | DECREASES ACTIVITY OF | Cytochrome P450 1A2 |
| Abiraterone Acetate | DECREASES ACTIVITY OF | Cytochrome P450 2C9 |
| Abiraterone Acetate | DECREASES ACTIVITY OF | Cytochrome P450 3A4 |
| Cytochrome P450 11B1, Mitochondrial | POSITIVELY REGULATES | Glucocorticoid Biosynthetic Process |
| Steroid 21-Hydroxylase | POSITIVELY REGULATES | Glucocorticoid Biosynthetic Process |
| Cytochrome P450 1A2 | POSITIVELY REGULATES | Glucocorticoid Biosynthetic Process |
| Cytochrome P450 2C9 | POSITIVELY REGULATES | Glucocorticoid Biosynthetic Process |
| Cytochrome P450 3A4 | POSITIVELY REGULATES | Glucocorticoid Biosynthetic Process |
| Glucocorticoid Biosynthetic Process | POSITIVELY CORRELATED WITH | Testosterone Biosynthetic Process |
| Testosterone Biosynthetic Process | POSITIVELY CORRELATED WITH | Increased Serum Testosterone Level |
| Increased Serum Testosterone Level | POSITIVELY CORRELATED WITH | Malignant Tumor Of Prostate |
|---------|-----------|---------|

Comment: In addition to inhibiting UniProt:P05093 (the main target according to [https://go.drugbank.com/drugs/DB05812#mechanism-of-action),](https://go.drugbank.com/drugs/DB05812#mechanism-of-action),) abiraterone also inhibits all these cytochrome P450s and can be useful in treating castration-resistant prostate cancers.

Reference: 
  - [https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology](https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology)
  - [https://www.kegg.jp/entry/D09701](https://www.kegg.jp/entry/D09701)
  - [https://en.wikipedia.org/wiki/21-Hydroxylase#Function](https://en.wikipedia.org/wiki/21-Hydroxylase#Function)
